Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 2, 2024 DTIL S 10b5-1 290 $10.32 $2,993 4,488 Direct -6.07% Disposed -41.4% (price as of 2026-10-05)
April 30, 2024 DTIL S 10b5-1 238 $10.03 $2,387 3,796 Direct -5.90% Disposed -39.7% (price as of 2026-10-05)
Jan. 22, 2024 DTIL S 10b5-1 21,526 $0.36 $7,749 94,982 Direct -18.48% Disposed -44.0% (price as of 2026-10-05)
April 27, 2023 DTIL S 10b5-1 7,771 $0.79 $6,139 56,496 Direct -12.09% Disposed -74.5% (price as of 2026-10-05)
March 6, 2023 DTIL S 10b5-1 9,473 $1.07 $10,136 38,240 Direct -19.85% Disposed -81.2% (price as of 2026-10-05)
April 27, 2022 DTIL S 10b5-1 7,775 $2.10 $16,328 18,260 Direct -29.86% Disposed -90.4% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 12, 2026 HURA Options (Right to Buy) Common Stock (156,240) $1.29 Feb. 12, 2036 156,240 Acquired
Jan. 2, 2025 HURA Options (Right to Buy) Common Stock (51,275) $4.11 Jan. 2, 2035 51,275 Acquired
Oct. 18, 2024 HURA Options (Right to Buy) Common Stock (13,553) $4.14 Feb. 28, 2034 13,553 Acquired
Oct. 18, 2024 HURA Options (Right to Buy) Common Stock (13,553) $3.69 Jan. 16, 2033 13,553 Acquired
May 1, 2024 DTIL Restricted Stock Units Common Stock (982) · · 982 Disposed
April 26, 2024 DTIL Restricted Stock Units Common Stock (868) · · 868 Disposed
Jan. 20, 2024 DTIL Restricted Stock Units Common Stock (60,012) · · 60,012 Disposed
April 26, 2023 DTIL Restricted Stock Units Common Stock (26,027) · · 26,027 Disposed
March 3, 2023 DTIL Restricted Stock Units Common Stock (29,453) · · 29,453 Acquired
Jan. 20, 2023 DTIL Restricted Stock Units Common Stock (180,000) · · 180,000 Acquired
April 26, 2022 DTIL Restricted Stock Units Common Stock (26,035) · · 26,035 Disposed
March 3, 2022 DTIL Restricted Stock Units Common Stock (88,343) · · 88,343 Acquired
March 3, 2022 DTIL Employee Stock Option (Right to Buy) Common Stock (140,299) $4.08 March 2, 2032 140,299 Acquired
June 7, 2021 DTIL Restricted Stock Units Common Stock (78,090) · · 78,090 Acquired
June 7, 2021 DTIL Employee Stock Option (Right to Buy) Common Stock (134,186) $11.34 June 6, 2031 134,186 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 22, 2024 HURA Common Stock 0 Direct
April 30, 2021 DTIL Employee Stock Option (Right to Buy)→ Common Stock (100,000) 100,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DTIL

M.D. Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2023 $475,721 $191,200 $217,800 $0 · · $25,250 $909,970

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.